← Zepp Health Corp
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.6b |
$314.9m
-79.77%
|
$530.2m
+68.36%
|
$834.9m
+57.47%
|
$986.0m
+18.10%
|
$980.8m
-0.53%
|
$600.7m
-38.76%
|
$351.5m
-41.49%
|
$182.6m
-48.04%
|
$258.9m
+41.78%
|
$271.9m
+5.03%
|
|
| Cost of Revenue | $1.3b |
$238.9m
-81.34%
|
$393.6m
+64.75%
|
$624.0m
+58.57%
|
$781.7m
+25.26%
|
$775.9m
-0.74%
|
$484.2m
-37.59%
|
$258.8m
-46.55%
|
$112.4m
-56.58%
|
$159.7m
+42.13%
|
$167.6m
+4.97%
|
|
| Gross Profit | $276.2m |
$76.0m
-72.47%
|
$136.6m
+79.70%
|
$210.8m
+54.30%
|
$204.2m
-3.12%
|
$204.9m
+0.31%
|
$116.4m
-43.17%
|
$92.6m
-20.44%
|
$70.2m
-24.19%
|
$99.2m
+41.23%
|
$104.3m
+5.12%
|
|
| Interest Income (Expense), Net | $754k |
$462k
-38.73%
|
$1.7m
+264.94%
|
$4.8m
+185.23%
|
$7.1m
+46.97%
|
— | — | — | — | — | $1.3m | |
| Research and Development Expense | $132.3m | $23.6m | $38.3m | $61.9m | $82.5m | $80.8m | $75.0m | $51.0m | $46.2m | $45.3m | $46.1m | |
| Selling and Marketing Expense | $27.8m | $6.8m | $14.0m | $26.1m | $55.0m | $68.8m | $66.7m | $44.3m | $46.5m | $53.8m | $86.7m | |
| General and Administrative Expense | $102.6m | $17.7m | $31.1m | $35.7m | $40.1m | $40.5m | $34.2m | $26.6m | $24.9m | $29.3m | $30.1m | |
| Amortization of Intangible Assets | — | $27k | $65k | $1.1m | $12.2m | $16.8m | $17.2m | $17.7m | $2.4m | $2.8m | — | |
| Operating Expenses | $262.8m | $48.1m | $83.4m | $123.7m | $177.5m | $190.1m | $175.9m | $121.8m | $117.5m | $128.4m | $132.8m | |
| Operating Income (Loss) | $13.4m |
$28.0m
+108.98%
|
$53.2m
+90.19%
|
$87.1m
+63.78%
|
$26.7m
-69.35%
|
$14.7m
-44.79%
|
($59.5m)
-503.50%
|
($29.2m)
+50.96%
|
($47.2m)
-61.98%
|
($29.2m)
+38.14%
|
($28.5m)
+2.34%
|
|
| Interest Expense | — | — | — | — | — | $7.0m | $8.3m | $6.7m | — | — | $6.0m | |
| Debt and Equity Securities, Unrealized Gain (Loss) | — | — | — | — | $1.9m | — | $7.5m | $176k | $2.0m | $76k | — | |
| Gain (Loss) on Investments | — | — | $1.1m | — | — | — | — | — | — | — | — | |
| Income (Loss) from Equity Method Investments | ($1.8m) | $431k | $254k | ($160k) | ($728k) | $6.4m | $2.6m | $1.2m | ($4.2m) | ($2.1m) | — | |
| Interest and Other Income | — | — | — | — | — | $2.6m | $1.8m | $3.1m | $3.7m | $1.5m | — | |
| Other Income | $14.7m | $699k | $1.3m | $1.9m | ($3.6m) | $4.3m | $6.4m | ($515k) | ($656k) | $56k | — | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $5.6m | $5.7m | $6.0m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | — | — | — | — | — | — | — | — | — | ($18.1m) | ($35.2m) | |
| Current Income Tax Expense (Benefit) | $21.6m | $46.6m | $84.9m | $105.7m | $42.3m | $31.5m | $379k | $2.9m | $248k | $299k | $2.6m | |
| Income Tax Expense (Benefit) | $3.1m | $4.2m | $7.6m | $11.2m | $4.8m | $1.7m | ($9.6m) | ($2.2m) | $13.7m | $2.5m | $2.6m | |
| Net Income (Loss) Attributable to Parent | $23.9m |
$25.8m
+7.62%
|
$49.5m
+91.91%
|
$82.6m
+67.06%
|
$35.1m
-57.57%
|
$21.6m
-38.32%
|
($41.8m)
-293.31%
|
($29.9m)
+28.53%
|
($75.7m)
-153.48%
|
($40.1m)
+47.09%
|
($40.0m)
+0.24%
|
|
| Net Income (Loss) Available to Common Stockholders, Basic | ($12.1m) |
$7.1m
+158.46%
|
$16.5m
+132.89%
|
$82.3m
+398.46%
|
$35.1m
-57.39%
|
$21.6m
-38.32%
|
($41.8m)
-293.31%
|
($29.9m)
+28.53%
|
($75.7m)
-153.48%
|
($40.1m)
+47.09%
|
($40.0m)
+0.24%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | — | ($90k) | ($542k) | ($262k) | $146k | ($134k) | ($100k) | ($65k) | ($75k) | — | ($40.0m) | |
| Preferred Stock Dividends, Income Statement Impact | — | — | $31 | — | — | — | — | — | — | — | — | |
| Undistributed Earnings (Loss) Allocated to Participating Securities, Basic | — | $12.3m | $1.8m | $352k | — | — | — | — | — | — | — | |
| Earnings Per Share, Basic | ($0.22) | $0.10 | $0.08 | $0.34 | $0.14 | $0.09 | ($0.17) | ($0.12) | ($0.29) | ($0.16) | ($2.56) | |
| Earnings Per Share, Diluted | ($0.22) | $0.10 | $0.07 | $0.32 | $0.13 | $0.08 | ($0.17) | ($0.12) | ($0.29) | ($0.16) | ($2.56) | |
| Weighted Average Number of Shares Outstanding, Basic | 55.6m | 67.8m | 211.9m | 243.6m | 248.5m | 252.2m | 246.3m | 243.1m | 258.9m | 254.4m | 15.9m | |
| Weighted Average Number of Shares Outstanding, Diluted | 55.6m | 76.3m | 225.0m | 256.0m | 260.4m | 264.4m | 246.3m | 243.1m | 258.9m | 254.4m | 15.9m | |
| Additional Financial Items | ||||||||||||
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount | — | — | $0 | $2.4m | $0 | $0 | $13.9m | $0 | $7.3m | $0 | — | |
| Goodwill, Impairment Loss | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Realized Investment Gains (Losses) | — | $365k | $38k | $262k | — | $2.1m | $87k | $109k | — | — | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.